{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,25]],"date-time":"2026-09-25T16:23:54Z","timestamp":1790353434321,"version":"4.1.0"},"reference-count":48,"publisher":"Frontiers Media SA","license":[{"start":{"date-parts":[[2019,3,11]],"date-time":"2019-03-11T00:00:00Z","timestamp":1552262400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["frontiersin.org"],"crossmark-restriction":true},"short-container-title":["Front. Cell. Infect. Microbiol."],"DOI":"10.3389\/fcimb.2019.00049","type":"journal-article","created":{"date-parts":[[2019,3,11]],"date-time":"2019-03-11T15:33:40Z","timestamp":1552318420000},"update-policy":"https:\/\/doi.org\/10.3389\/crossmark-policy","source":"Crossref","is-referenced-by-count":47,"title":["Activity and Impact on Resistance Development of Two Antivirulence Fluoropyrimidine Drugs in Pseudomonas aeruginosa"],"prefix":"10.3389","volume":"9","author":[{"given":"Francesco","family":"Imperi","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ersilia V.","family":"Fiscarelli","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Daniela","family":"Visaggio","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Livia","family":"Leoni","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Paolo","family":"Visca","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1965","published-online":{"date-parts":[[2019,3,11]]},"reference":[{"key":"B1","doi-asserted-by":"publisher","first-page":"300","DOI":"10.1038\/nrmicro3232","article-title":"Targeting virulence: can we make evolution-proof drugs?","volume":"12","author":"Allen","year":"2014","journal-title":"Nat. Rev. Microbiol"},{"key":"B2","doi-asserted-by":"publisher","first-page":"162","DOI":"10.1007\/s00284-007-9050-3","article-title":"Pathways of pyrimidine salvage in Pseudomonas and former Pseudomonas: detection of recycling enzymes using high-performance liquid chromatography","volume":"56","author":"Beck","year":"2008","journal-title":"Curr. Microbiol"},{"key":"B3","doi-asserted-by":"publisher","first-page":"5641","DOI":"10.1128\/AAC.01097-15","article-title":"Pyoverdine and proteases affect the response of Pseudomonas aeruginosa to gallium in human serum","volume":"59","author":"Bonchi","year":"2015","journal-title":"Antimicrob. Agents Chemother"},{"key":"B4","doi-asserted-by":"publisher","first-page":"80","DOI":"10.1016\/j.jconrel.2016.07.029","article-title":"Development of inhalable hyaluronan\/mannitol composite dry powders for flucytosine repositioning in local therapy of lung infections","volume":"238","author":"Costabile","year":"2016","journal-title":"J. Control. Release"},{"key":"B5","doi-asserted-by":"publisher","first-page":"e01296","DOI":"10.1128\/AAC.01296-18","article-title":"Identification of FDA-approved drugs as antivirulence agents targeting the pqs quorum-sensing system of Pseudomonas aeruginosa","volume":"62","author":"D'Angelo","year":"2018","journal-title":"Antimicrob. Agents Chemother"},{"key":"B6","doi-asserted-by":"publisher","first-page":"384","DOI":"10.1007\/s002030100278","article-title":"Study of pyoverdine type and production by Pseudomonas aeruginosa isolated from cystic fibrosis patients: prevalence of type II pyoverdine isolates and accumulation of pyoverdine-negative mutations","volume":"175","author":"De Vos","year":"2001","journal-title":"Arch. Microbiol"},{"key":"B7","doi-asserted-by":"publisher","first-page":"457","DOI":"10.1038\/nrd.2017.23","article-title":"Different drugs for bad bugs: antivirulence strategies in the age of antibiotic resistance","volume":"16","author":"Dickey","year":"2017","journal-title":"Nat. Rev. Drug Discov"},{"key":"B8","doi-asserted-by":"publisher","first-page":"4379","DOI":"10.1111\/1462-2920.12863","article-title":"Integrated whole-genome screening for Pseudomonas aeruginosa virulence genes using multiple disease models reveals that pathogenicity is host specific","volume":"17","author":"Dubern","year":"2015","journal-title":"Environ. Microbiol"},{"key":"B9","doi-asserted-by":"crossref","first-page":"136","DOI":"10.1128\/.61.2.136-169.1997","article-title":"Common themes in microbial pathogenicity revisited","volume":"61","author":"Finlay","year":"1997","journal-title":"Microbiol. Mol. Biol. Rev"},{"key":"B10","doi-asserted-by":"publisher","first-page":"4","DOI":"10.1038\/ismej.2015.84","article-title":"Can resistance against quorum-sensing interference be selected?","volume":"10","author":"Garc\u00eda-Contreras","year":"2016","journal-title":"ISME J"},{"key":"B11","doi-asserted-by":"publisher","first-page":"8","DOI":"10.1111\/2049-632X.12039","article-title":"Resistance to the quorum-quenching compounds brominated furanone C-30 and 5-fluorouracil in Pseudomonas aeruginosa clinical isolates","volume":"68","author":"Garc\u00eda-Contreras","year":"2013","journal-title":"Pathog. Dis"},{"key":"B12","doi-asserted-by":"publisher","first-page":"238","DOI":"10.1016\/j.mrfmmm.2005.05.021","article-title":"5-fluorouracil forward mutation assay in Salmonella: determination of mutational target and spontaneous mutational spectra","volume":"578","author":"Glaab","year":"2005","journal-title":"Mutat. Res"},{"key":"B13","doi-asserted-by":"publisher","first-page":"178","DOI":"10.3389\/fmicb.2014.00178","article-title":"Antivirulence activity of azithromycin in Pseudomonas aeruginosa","volume":"5","author":"Imperi","year":"2014","journal-title":"Front. Microbiol"},{"key":"B14","doi-asserted-by":"publisher","first-page":"7458","DOI":"10.1073\/pnas.1222706110","article-title":"Repurposing the antimycotic drug flucytosine for suppression of Pseudomonas aeruginosa pathogenicity","volume":"110","author":"Imperi","year":"2013","journal-title":"Proc. Natl. Acad. Sci. U.S.A"},{"key":"B15","doi-asserted-by":"publisher","first-page":"1630","DOI":"10.1111\/j.1462-2920.2010.02210.x","article-title":"Transcriptional control of the pvdS iron starvation sigma factor gene by the master regulator of sulfur metabolism CysB in Pseudomonas aeruginosa","volume":"12","author":"Imperi","year":"2010","journal-title":"Environ. Microbiol"},{"key":"B16","doi-asserted-by":"publisher","first-page":"20440","DOI":"10.1073\/pnas.0908760106","article-title":"Molecular basis of pyoverdine siderophore recycling in Pseudomonas aeruginosa","volume":"106","author":"Imperi","year":"2009","journal-title":"Proc. Natl. Acad. Sci. U.S.A"},{"key":"B17","doi-asserted-by":"publisher","first-page":"339","DOI":"10.1016\/j.tips.2017.01.004","article-title":"Small molecules that sabotage bacterial virulence","volume":"38","author":"Johnson","year":"2017","journal-title":"Trends Pharmacol. Sci"},{"key":"B18","doi-asserted-by":"publisher","first-page":"e00217","DOI":"10.1128\/mSphere.00217-16","article-title":"A high-content, phenotypic screen identifies fluorouridine as an inhibitor of pyoverdine biosynthesis and Pseudomonas aeruginosa Virulence","volume":"1","author":"Kirienko","year":"2016","journal-title":"mSphere"},{"key":"B19","doi-asserted-by":"publisher","first-page":"3140","DOI":"10.2174\/138161207782110408","article-title":"The targets of currently used antibacterial agents: lessons for drug discovery","volume":"13","author":"Lange","year":"2007","journal-title":"Curr. Pharm. Des"},{"key":"B20","doi-asserted-by":"publisher","first-page":"R90","DOI":"10.1186\/gb-2006-7-10-r90","article-title":"Genomic analysis reveals that Pseudomonas aeruginosa virulence is combinatorial","volume":"7","author":"Lee","year":"2006","journal-title":"Genome Biol"},{"key":"B21","doi-asserted-by":"publisher","first-page":"3196","DOI":"10.1111\/j.1462-2920.2010.02292.x","article-title":"The global regulator Crc modulates metabolism, susceptibility to antibiotics and virulence in Pseudomonas aeruginosa","volume":"12","author":"Linares","year":"2010","journal-title":"Environ. Microbiol"},{"key":"B22","doi-asserted-by":"publisher","first-page":"330","DOI":"10.1038\/nrc1074","article-title":"5-fluorouracil: mechanisms of action and clinical strategies","volume":"3","author":"Longley","year":"2003","journal-title":"Nat. Rev. Cancer"},{"key":"B23","doi-asserted-by":"publisher","first-page":"493","DOI":"10.1038\/ismej.2011.122","article-title":"Quorum quenching quandary: resistance to antivirulence compounds","volume":"6","author":"Maeda","year":"2012","journal-title":"ISME J"},{"key":"B24","doi-asserted-by":"publisher","first-page":"e00966","DOI":"10.1128\/mBio.00966-14","article-title":"Within-host evolution of Pseudomonas aeruginosa reveals adaptation toward iron acquisition from hemoglobin","volume":"5","author":"Marvig","year":"2014","journal-title":"MBio"},{"key":"B25","doi-asserted-by":"publisher","first-page":"57","DOI":"10.1038\/ng.3148","article-title":"Convergent evolution and adaptation of Pseudomonas aeruginosa within patients with cystic fibrosis","volume":"47","author":"Marvig","year":"2015","journal-title":"Nat. Genet"},{"key":"B26","doi-asserted-by":"publisher","first-page":"41","DOI":"10.1016\/j.mib.2016.06.001","article-title":"Considerations and caveats in anti-virulence drug development","volume":"33","author":"Maura","year":"2016","journal-title":"Curr. Opin. Microbiol"},{"key":"B27","doi-asserted-by":"publisher","first-page":"2324","DOI":"10.1128\/IAI.00098-16","article-title":"Role of iron uptake systems in Pseudomonas aeruginosa virulence and airway infection","volume":"84","author":"Minandri","year":"2016","journal-title":"Infect. Immun"},{"key":"B28","doi-asserted-by":"publisher","first-page":"147","DOI":"10.1007\/82_2015_490","article-title":"Anti-virulence strategies to target bacterial infections","volume":"398","author":"M\u00fchlen","year":"2016","journal-title":"Curr. Top. Microbiol. Immunol"},{"key":"B29","doi-asserted-by":"crossref","first-page":"899","DOI":"10.1128\/iai.28.3.899-908.1980","article-title":"Toxin A-deficient mutants of Pseudomonas aeruginosa PA103: isolation and characterization","volume":"28","author":"Ohman","year":"1980","journal-title":"Infect. Immun"},{"key":"B30","doi-asserted-by":"publisher","first-page":"11392","DOI":"10.1038\/s41598-017-11892-9","article-title":"Effect of efflux pump inhibition on Pseudomonas aeruginosa transcriptome and virulence","volume":"7","author":"Rampioni","year":"","journal-title":"Sci. Rep"},{"key":"B31","doi-asserted-by":"publisher","first-page":"13","DOI":"10.1042\/ETLS20160018","article-title":"Drug repurposing for antivirulence therapy against opportunistic bacterial pathogens","volume":"1","author":"Rampioni","year":"","journal-title":"Emerg. Top. Life Sci"},{"key":"B32","doi-asserted-by":"publisher","first-page":"16912","DOI":"10.1038\/s41598-018-35087-y","article-title":"Pseudomonas aeruginosa mutants defective in glucose uptake have pleiotropic phenotype and altered virulence in non-mammal infection models","volume":"8","author":"Raneri","year":"2018","journal-title":"Sci. Rep"},{"key":"B33","doi-asserted-by":"publisher","first-page":"282","DOI":"10.3389\/fmicb.2015.00282","article-title":"Drug repurposing as an alternative for the treatment of recalcitrant bacterial infections","volume":"6","author":"Rangel-Vega","year":"2015","journal-title":"Front. Microbiol"},{"key":"B34","doi-asserted-by":"publisher","first-page":"117","DOI":"10.1038\/nrd3013","article-title":"Anti-virulence strategies to combat bacteria-mediated disease","volume":"9","author":"Rasko","year":"2010","journal-title":"Nat. Rev. Drug Discov"},{"key":"B35","doi-asserted-by":"publisher","first-page":"246","DOI":"10.1093\/emph\/eoy026","article-title":"Probing the evolutionary robustness of two repurposed drugs targeting iron uptake in Pseudomonas aeruginosa","volume":"2018","author":"Rezzoagli","year":"2018","journal-title":"Evol. Med. Public Health"},{"key":"B36","doi-asserted-by":"publisher","first-page":"379","DOI":"10.1111\/cbdd.12517","article-title":"Virulence-targeted antibacterials: concept, promise, and susceptibility to resistance mechanisms","volume":"86","author":"Ruer","year":"2015","journal-title":"Chem. Biol. Drug. Des"},{"key":"B37","doi-asserted-by":"publisher","first-page":"901","DOI":"10.1093\/infdis\/jiv533","article-title":"Important complexities of the antivirulence target paradigm: a novel ostensibly resistance-avoiding approach for treating infections","volume":"213","author":"Russo","year":"2016","journal-title":"J. Infect. Dis"},{"key":"B38","volume-title":"Molecular Cloning: a Laboratory Manual, 2nd Edn","author":"Sambrook","year":"1989"},{"key":"B39","doi-asserted-by":"publisher","first-page":"1331","DOI":"10.1111\/j.1365-2958.2007.05984.x","article-title":"Molecular mechanisms of virstatin resistance by non-O1\/non-O139 strains of Vibrio cholerae","volume":"66","author":"Shakhnovich","year":"2007","journal-title":"Mol. Microbiol"},{"key":"B40","doi-asserted-by":"publisher","first-page":"9162","DOI":"10.1021\/acs.chemrev.6b00184","article-title":"Plant natural products targeting bacterial virulence factors","volume":"116","author":"Silva","year":"2016","journal-title":"Chem. Rev"},{"key":"B41","doi-asserted-by":"publisher","first-page":"1157","DOI":"10.2174\/1568026616666160930131737","article-title":"Repurposing of anticancer drugs for the treatment of bacterial infections","volume":"17","author":"Soo","year":"2017","journal-title":"Curr. Top. Med. Chem"},{"key":"B42","doi-asserted-by":"publisher","first-page":"529","DOI":"10.1038\/nrd4572","article-title":"ESKAPEing the labyrinth of antibacterial discovery","volume":"14","author":"Tommasi","year":"2015","journal-title":"Nat. Rev. Drug Discov"},{"key":"B43","doi-asserted-by":"publisher","first-page":"62","DOI":"10.1111\/j.1751-7915.2008.00060.x","article-title":"Uracil influences quorum sensing and biofilm formation in Pseudomonas aeruginosa and fluorouracil is an antagonist","volume":"2","author":"Ueda","year":"2009","journal-title":"Microb. Biotechnol"},{"key":"B44","doi-asserted-by":"publisher","first-page":"171","DOI":"10.1093\/jac\/46.2.171","article-title":"Flucytosine: a review of its pharmacology, clinical indications, pharmacokinetics, toxicity and drug interactions","volume":"46","author":"Vermes","year":"2000","journal-title":"J. Antimicrob. Chemother"},{"key":"B45","doi-asserted-by":"publisher","first-page":"902","DOI":"10.3389\/fmicb.2015.00902","article-title":"Cell aggregation promotes pyoverdine-dependent iron uptake and virulence in Pseudomonas aeruginosa","volume":"6","author":"Visaggio","year":"2015","journal-title":"Front. Microbiol"},{"key":"B46","doi-asserted-by":"publisher","first-page":"22","DOI":"10.1016\/j.tim.2006.11.004","article-title":"Pyoverdine siderophores: from biogenesis to biosignificance","volume":"15","author":"Visca","year":"2007","journal-title":"Trends Microbiol"},{"key":"B47","first-page":"149","article-title":"Utilization of pyrimidines and pyrimidine analogues by fluorescent pseudomonads","volume":"47","author":"West","year":"1986","journal-title":"Microbios"},{"key":"B48","doi-asserted-by":"publisher","first-page":"918","DOI":"10.1128\/JB.00911-10","article-title":"The sensor kinase CbrA is a global regulator that modulates metabolism, virulence, and antibiotic resistance in Pseudomonas aeruginosa","volume":"193","author":"Yeung","year":"2011","journal-title":"J. Bacteriol"}],"container-title":["Frontiers in Cellular and Infection Microbiology"],"original-title":[],"link":[{"URL":"https:\/\/www.frontiersin.org\/article\/10.3389\/fcimb.2019.00049\/full","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,9,13]],"date-time":"2022-09-13T17:13:24Z","timestamp":1663089204000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.frontiersin.org\/article\/10.3389\/fcimb.2019.00049\/full"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2019,3,11]]},"references-count":48,"alternative-id":["10.3389\/fcimb.2019.00049"],"URL":"https:\/\/doi.org\/10.3389\/fcimb.2019.00049","relation":{},"ISSN":["2235-2988"],"issn-type":[{"value":"2235-2988","type":"electronic"}],"subject":[],"published":{"date-parts":[[2019,3,11]]},"article-number":"49"}}